-
Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis.
Galazis N, Docheva N, Simillis C, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 2014;181:45-53. pdf -
Longitudinal changes in uterine artery Doppler and blood pressure and risk of pre-eclampsia.
Khalil A, Garcia-Mandujano R, Maiz N, Elkhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;43:541-7. pdf -
Longitudinal changes in maternal hemodynamics in a population at risk for pre-eclampsia.
Khalil A, Garcia-Mandujano R, Maiz N, Elkhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:197-204. pdf -
Early prediction of preeclampsia.
Poon LC, Nicolaides KH.
Obstet Gynecol Int 2014;2014:297397. pdf -
Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;35:249-57. pdf -
Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.
Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014;36:28-37. pdf -
Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation.
Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014;35:240-8. pdf -
Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation.
Garcia-Tizon Larroca S, Tayyar A, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014;36:9-17. pdf -
Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
Tayyar A, Garcia-Tizon Larroca S, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014;36:18-27. pdf -
Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;36:106-16.. pdf -
First trimester Angiotensinogen: Kallikrein ratio is raised in women who develop severe early-onset pre-eclampsia.
Breslin E, Slade S, Akolekar R, Nicolaides KH, Scrivens J, Quenby S.
Arch Dis Child Fetal Neonatal Ed 2014;99 Suppl 1:A5. pdf -
Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk of preeclampsia.
Khalil A, Maiz N, Garcia-Mandujano R, ElKhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:402-10. pdf -
First-trimester maternal factors and biomarker screening for preeclampsia.
Poon LC, Nicolaides KH.
Prenat Diagn 2014;34:618-27. pdf -
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Bujold E, Roberge S, Nicolaides KH.
Prenat Diagn 2014;34:642-8. pdf -
Prediction of recurrent preeclampsia using first-trimester uterine artery Doppler.
Demers S, Bujold E, Arenas E, Castro A, Nicolaides KH.
Am J Perinatol 2014;31:99-104. -
Longitudinal changes in uterine artery Doppler and blood pressure and the risk of preeclampsia.
Khalil A, Garcia-Mandujano R, Maiz N, Elkhaouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:197-204. -
Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia.
Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH.
BJOG 2000;107:795-7. -
First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications.
Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH.
BJOG 2000;107:1265-70. -
Increased fetal erythroblasts in women who subsequently develop pre-eclampsia.
Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH.
Hum Reprod 2000;15:1624-8. -
One-stage screening for pregnancy complications by color doppler assessment of the uterine arteries at 23 weeks' gestation.
Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH.
Obstet Gynecol 2000;96:559-64.